IL17F and psoriasis: In addition, other limitations of our study were as follows: few published studies on the IL-17F rs763780 and IL-17RA rs4819554 polymorphisms and their impact on biological treatment in patients with psoriasis; the lack of NAPSI score registration at baseline and in evolution, so we could not evaluate the genotype effect on the severity of the nail damage or the response to treatment.